Compare EHang Holdings Ltd - ADR (EH) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
EHang Holdings Ltd - ADR vs Halozyme Therapeutics Inc. Common Stock — how do they compare? EHang Holdings Ltd - ADR trades at $4.17 (market cap $309.45M), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 40.7× EHang Holdings Ltd - ADR's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, EHang Holdings Ltd - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold EHang Holdings Ltd - ADR for 47 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| EH | HALO | |
|---|---|---|
Market Cap | $309.45M | $12.58B |
Volume | 765,799 | 2,179,278 |
Sector | Industrials | Health |
52-Week High | $18.94 | $115.22 |
52-Week Low | $4.03 | $61.63 |
Typical Hold Time | 47 Days | 1 Days |
Enterprise Value | $261.14M | $14.49B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EHang Holdings (EH) trades at $4.19, up 1.21% with bearish technical signals despite recent earnings beats. The company shows mixed fundamentals with strong revenue growth from $44M in 2022 to $418M in 2025, but deep losses persist with a -66% net margin. Recent news includes regulatory investigations and international expansion into Vietnam, creating conflicting sentiment signals for investors.
Outlook remains challenging with significant execution risks and negative profitability, though the eVTOL market offers long-term potential. The stock faces headwinds from regulatory scrutiny and cash burn, requiring careful risk assessment despite trading near technical support levels.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About EHang Holdings Ltd - ADR
EHang Holdings Ltd is an autonomous aerial vehicle (AAV) technology platform company. It focuses on making safe, autonomous and eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with AAV products and commercial solutions: air mobility (including passenger transportation and logistics), smart city management and aerial media solutions. As the forerunner of cutting-edge AAV technologies and commercial solutions in the global Urban Air Mobility industry, it continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
Read more on EH →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
